Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults with ... PR Newswire (press release) Formal drug interaction studies have not been performed with rituximab or natalizumab; however, because of the nature of the adverse events seen with these combinations with TNF blocker therapy, similar toxicities may also result from the use of CIMZIA ... |
